Emicizumab in people with moderate or mild haemophilia A (HAVEN 6): a multicentre, open-label, single-arm, phase 3 study.
The Lancet. Haematology
View this publicationThe Lancet. Haematology
View this publicationThe New England journal of medicine
View this publicationPharmaceutics
View this publicationJournal of cardiovascular computed tomography
View this publicationScientific reports
View this publicationJHEP reports : innovation in hepatology
View this publicationMovement disorders : official journal of the Movement Disorder Society
View this publicationInternational journal of molecular sciences
View this publicationBMC infectious diseases
View this publicationEuropean urology
View this publication